A synthetic red dye used in thousands of food and drink products has been banned by US officials after being linked to cancer. Bright cherry-colored Red No 3 had its use authorization revoked on Wednesday by the US Food and Drug Administration (FDA),
The artificial food dye can be found in candy, beverages, chips and other packaged foods — often consumed by children.
Red No. 3. is commonly found in candy, gum, and cookies, including Brach’s candy corn, Betty Crocker sprinkles, and strawberry Ensure over links to cancer.
The Food and Drug Administration announced Wednesday it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the food coloring dye has been linked to cancer in laboratory animals.
Studies show that high doses could cause cancer in rats, but the regulators maintain that no evidence exists that ingesting the coloring causes cancer in humans.
By Melissa Patrick Kentucky Health News The U.S. Food and Drug Administration has banned Red Dye No. 3 from food, beverages and drugs. The Center for Science in the Public Interest, which brought the petition to ban red No.
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .
Food dye Red No. 3 has been banned by the FDA. Are there other food additives that could soon be forbidden the same way?
The FDA has banned Red No. 3, a dye linked to cancer, from food and drinks, impacting products like sports drinks and cereals.
A new initiative, led by the Indian Medical Association (IMA) and the Federation of Obstetric and Gynaecological Societies of India (FOGSI), seeks to eliminate cervical cancer in India. As part of the initiative,
Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on her first National Institutes of Health (NIH) grant review panel at the end of January. On Wednesday, to her surprise, that meeting was abruptly canceled.